NCT00093353 2026-04-14
N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium
Phase 1 Completed
Clinical Trials
11 trialsNCT07524829 2026-04-13
Telenursing for the Early Detection and Management of Side Effects Associated With Cyclin-Dependent Kinase Inhibitors in Breast Cancer Patients
Azienda Sanitaria Locale di Asti
Phase NA Recruiting
NCT07169851 2026-03-20
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
Eli Lilly and Company
Phase 2 Recruiting
NCT07238075 2026-02-17
ADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers
Adcytherix SAS
Phase 1 Recruiting
NCT00400946 2026-02-13
05-001: Treatment of Acute Lymphoblastic Leukemia in Children
Dana-Farber Cancer Institute
Phase 3 Completed
NCT04305145 2026-01-29
Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis
Massachusetts General Hospital
Phase 2 Active not recruiting
NCT07319364 2026-01-06
A Real-World Study of Fecal Transplants for Cancer Therapy Side Effects
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 1 Recruiting
NCT06120712 2025-12-23
MIZAR-002
Shanghai Juncell Therapeutics
Phase 1/2 Completed
NCT05417750 2025-12-10
MIZAR-001
Shanghai Juncell Therapeutics
Phase 1 Completed
NCT07063706 2025-07-18
Pharmaceutical Care for Patients Using Capecitabine
Faculdade de Farmácia
Phase NA Completed
NCT06789601 2025-06-19
Evaluating Informatics-assisted Immune-related Adverse Event Detection to Improve Registration Onto a Biorepository
Brigham and Women's Hospital
Phase 1/2 Recruiting